Advertisement

Reviews in Endocrine and Metabolic Disorders

, Volume 5, Issue 3, pp 221–225 | Cite as

Pathogenesis of Hypertension in Diabetes

  • Sameer N. Stas
  • Fadi A. El-Atat
  • James R. Sowers
Article
hypertension diabetes insulin resistance insulin IGF-1 vascular dysfunction 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lehto S, Ronnemaa T, Pyorala K, Laakso M. Stroke. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. 1996;27:63-68.Google Scholar
  2. 2.
    Sowers JR, Haffner S. Treatment of cardiovascular and renal risk factors in the diabetic hypertensive. Hypertension 2002;40:781-788.Google Scholar
  3. 3.
    Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993;11:309-317.Google Scholar
  4. 4.
    Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest 1985;75:809-817.Google Scholar
  5. 5.
    Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334:374-381.Google Scholar
  6. 6.
    Reaven GM, Chang H. Relationship between blood pressure, plasma insulin and triglyceride concentration, and insulin action in spontaneous hypertensive and Wistar-Kyoto rats. Am J Hypertens 1991;4:34-38.Google Scholar
  7. 7.
    Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BV, et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991;324:733-739.Google Scholar
  8. 8.
    Sawicki PT, Heinemann L, Starke A, Berger M. Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma. Diabetologia 1992;35:649-652.8. Anderson EA.Google Scholar
  9. 9.
    Mark AL. The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension. Hypertension 1993;21:136-141.Google Scholar
  10. 10.
    Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 1997;29:691-699.Google Scholar
  11. 11.
    Sowers JR, Sowers PS, Peuler JD. Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis. J Lab Clin Med 1994;123:647-652.Google Scholar
  12. 12.
    Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Christensen NJ, Bent-Hansen L, Nielsen MD. Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987;30:610-617.Google Scholar
  13. 13.
    Weinberger MH. Salt sensitive human hypertension. Endocr Res 1991;17:43-51.Google Scholar
  14. 14.
    Sowers JR. Effects of insulin and IGF-I on vascular smooth muscle glucose and cation metabolism. Diabetes 1996;45:S47-51.Google Scholar
  15. 15.
    Melo LG, Veress AT, Chong CK, Pang SC, Flynn TG, Sonnenberg H. Salt-sensitive hypertension in ANP knockout mice: Potential role of abnormal plasma 0renin activity. Am J Physiol 1998;274:R255-R261.Google Scholar
  16. 16.
    Yano Y, Katsuki A, Gabazza EC, Ito K, Fujii M, Furuta M, Tuchihashi K, Goto H, Nakatani K, Hori Y, Sumida Y, Adachi Y. Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria. J Clin Endocrinol Metab 1999;84:2353-2356.Google Scholar
  17. 17.
    Landsberg L. Hyperinsulinemia: Possible role in obesity-induced hypertension. Hypertension 1992;19:I61-I66.Google Scholar
  18. 18.
    Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981;30:219-225.Google Scholar
  19. 19.
    Takagi M, Tanaka Y, Yamasaki Y, Yamamoto M, Hori M, Nakaniwa T, Niwa M, Uchino H, Tamura Y, Nomiyama T, Watada H, Kawamori R. Responsiveness of insulin-induced cardiac sympathetic nerve activation associates with blood pressure regulation in diabetics. Am J Physiol Endocrinol Metab 2003;284:E1022-1026.Google Scholar
  20. 20.
    Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, Lambert G. Sympathetic nervous system and insulin resistance: From obesity to diabetes. Am J Hypertens 2001;11:304S-309S.Google Scholar
  21. 21.
    Landsberg L. Insulin and the sympathetic nervous system in the pathophysiology of hypertension. Blood Press Suppl 1996;1:25-29.Google Scholar
  22. 22.
    Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, Lambert G. Sympathetic nervous system and insulin resistance: From obesity to diabetes. Am J Hypertens 2001;14:304S-309S.Google Scholar
  23. 23.
    Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: Role of leptin and sympathetic nervous system. Am J Hypertens 2001;14:103S-115S.Google Scholar
  24. 24.
    Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: An update. Hypertension 2001;37:1053-1059.Google Scholar
  25. 25.
    Nickenig G, Roling J, Strehlow K, Schnabel P, Bohm M. Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation 1998;98:2453-2460.Google Scholar
  26. 26.
    McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001;86:713-718.Google Scholar
  27. 27.
    Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994;94:1172-1179.Google Scholar
  28. 28.
    Walsh MF, Barazi M, Pete G, Muniyappa R, Dunbar JC, Sowers JR. Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: Role of vascular nitric oxide. Endocrinology 1996;137:1798-1803.Google Scholar
  29. 29.
    Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996;27:567-574.Google Scholar
  30. 30.
    Ouvina SM, La Greca RD, Zanaro NL, Palmer L, Sassetti B. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients. Thromb Res 2001;102:107-114.Google Scholar
  31. 31.
    Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP. Impaired nitric oxide synthase pathway in diabetes mellitus: Role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2002;106:987-992.Google Scholar
  32. 32.
    Dzau VJ. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: A unifying hypothesis. Hypertension 2001;37:1047-1052.Google Scholar
  33. 33.
    McFarlane SI, Kumar A, Sowers JR. Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease. Am J Cardiol 2003;91:30H-37H.Google Scholar
  34. 34.
    Hamuro M, Polan J, Natarajan M, Mohan S. High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration. Atherosclerosis 2002;162:277-287.Google Scholar
  35. 35.
    Ferri C, Pittoni V, Piccoli A, Laurenti O, Cassone MR, Bellini C, Properzi G, Valesini G, De Mattia G, Santucci A. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab 1995;80:829-835.Google Scholar
  36. 36.
    Jiang ZY, Zhou QL, Chatterjee A, Feener EP, Myers MG Jr, White MF, King GL. Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes 1999;48:1120-1130.Google Scholar
  37. 37.
    Satoh H, Tsukamoto K, Hashimoto Y, Hashimoto N, Togo M, Hara M, Maekawa H, Isoo N, Kimura S, Watanabe T. Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: A new possible role of PPARgamma on vascular endothelial function. Biochem Biophys Res Commun 1999;254:757-763.Google Scholar
  38. 38.
    Muniyappa R, Srinivas PR, Ram JL, Walsh MF, Sowers JR. Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells. Hypertension 1998;31:289-295.Google Scholar
  39. 39.
    Yasunari K, Kohno M, Kano H, Yokokawa K, Minami M, Yoshikawa J. Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose. Circulation 1999;99:1370-1378.Google Scholar
  40. 40.
    Hogan M, Cerami A, Bucala R. Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus. J Clin Invest 1992;90:1110-1115.Google Scholar
  41. 41.
    Murphy LJ, Ghahary A, Chakrabarti S. Insulin regulation of IGF-I expression in rat aorta. Diabetes 1990;39:657-662.Google Scholar
  42. 42.
    Kamide K, Hori MT, Zhu JH, Barrett JD, Eggena P, Tuck ML. Insulin-mediated growth in aortic smooth muscle and the vascular renin-angiotensin system. Hypertension 1998;32:482-487.Google Scholar
  43. 43.
    Begum N, Sandu OA, Duddy N. Negative regulation of rho signaling by insulin and its impact on actin cytoskeleton organization in vascular smooth muscle cells: Role of nitric oxide and cyclic guanosine monophosphate signaling pathways. Diabetes 2002;51:2256-2263.Google Scholar
  44. 44.
    Standley PR, Ram JL, Sowers JR. Insulin attenuation of vasopressin-induced calcium responses in arterial smooth muscle from Zucker rats. Endocrinology 1993;133:1693-1699.Google Scholar
  45. 45.
    Levy J, Gavin JR 3rd, Sowers JR. Diabetes mellitus: A disease of abnormal cellular calcium metabolism? Am J Med 1994;96:260-273.Google Scholar
  46. 46.
    Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993;21:1024-1029.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Sameer N. Stas
    • 1
    • 2
  • Fadi A. El-Atat
    • 1
    • 2
  • James R. Sowers
    • 1
    • 2
  1. 1.Department of Internal MedicineUniversity of Missouri-ColumbiaHS Truman VAMCColumbia, MO;
  2. 2.Department of Internal MedicineState University of New York, Brooklyn VAMCBrooklyn

Personalised recommendations